Iovance BiotherapeuticsIOVA
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 295 institutions reported holding Iovance Biotherapeutics Inc. (IOVA) in their 13F filings, up 22 from Q1 2024. 62 opened new positions and 40 sold out. The largest holders were Vanguard Group Inc. ($208.1M), Perceptive Advisors LLC ($208.0M) and MHR Fund Management LLC ($192.5M). 5 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Iovance Biotherapeutics Inc.
- CUSIP
- 462260100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 62 | $46.5M |
| Exits | 40 | $62.9M |
All 13F filers, Q1 2024 → Q2 2024: 38,300,097 shares bought and 22,271,622 shares sold, net +16,028,475 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 295 holders
| Vanguard Group Inc. | 0.00% | Add +4.2% | 25,950,644 | $208.1M |
| Perceptive Advisors LLC | 5.02% | Add +34.6% | 25,933,142 | $208.0M |
| MHR Fund Management LLC | 23.45% | No change | 23,997,103 | $192.5M |
| BlackRock Inc. | 0.00% | Add +6.5% | 21,225,119 | $170.2M |
| State Street Corp. | 0.00% | Add +21.4% | 12,625,177 | $101.3M |
| Avoro Capital Advisors LLC | 1.25% | No change | 11,700,000 | $93.8M |
| Soleus Capital Management, L.P. | 5.34% | Add +115.3% | 7,548,000 | $60.5M |
| Geode Capital Management, LLC | 0.00% | Add +5.1% | 5,786,532 | $46.4M |
| Artisan Partners Limited Partnership | 0.06% | Reduce -0.5% | 5,111,409 | $41.0M |
| Balyasny Asset Management L.P. | 0.10% | Add +278.1% | 4,540,560 | $36.4M |
| Long Focus Capital Management, LLC | 3.43% | Add +195.1% | 4,132,000 | $33.1M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -33.9% | 3,482,402 | $27.9M |
| JPMorgan Chase & Co. | 0.00% | Reduce -21.6% | 3,438,232 | $27.6M |
| Morgan Stanley | 0.00% | Add +4.9% | 2,822,863 | $22.6M |
| Hood River Capital Management LLC | 0.45% | Add +4.1% | 2,732,427 | $21.9M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -30.7% | 2,621,784 | $21.0M |
| Principal Financial Group Inc. | 0.01% | Add +26.4% | 2,536,243 | $20.3M |
| Voloridge Investment Management, LLC | 0.07% | Reduce -28.7% | 2,491,659 | $20.0M |
| MPM Bioimpact LLC | 2.95% | Add +7.6% | 2,366,714 | $19.0M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -21.1% | 2,265,555 | $18.2M |
| Bank of America Corp. | 0.00% | Add +41.4% | 2,167,225 | $17.4M |
| Northern Trust Corp. | 0.00% | Reduce -2.7% | 2,166,958 | $17.4M |
| Palo Alto Investors LP | 1.97% | Add +0.2% | 2,116,403 | $17.0M |
| T. Rowe Price Investment Management, Inc. | 0.01% | Add +56.1% | 2,050,500 | $16.4M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +1009.0% | 1,994,500 | $16.0M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +3.8% | 1,984,945 | $15.9M |
| Eagle Asset Management Inc. | 0.08% | Add +251.7% | 1,937,709 | $15.6M |
| Rice Hall James & Associates, LLC | 0.79% | Reduce -4.5% | 1,636,025 | $13.1M |
| Marshall Wace, LLP | 0.02% | New | 1,612,055 | $12.9M |
| Summit Partners Public Asset Management, LLC | 0.57% | Reduce -47.6% | 1,555,408 | $12.5M |
| 683 Capital Management, LLC | 1.41% | Add +22.4% | 1,500,000 | $12.0M |
| Braidwell LP | 0.60% | Add +122.2% | 1,466,610 | $11.8M |
| Nuveen Asset Management, LLC | 0.00% | Reduce -19.7% | 1,328,117 | $10.7M |
| C WorldWide Group Holding A/S | 0.11% | Add +18.9% | 1,260,000 | $10.1M |
| New York State Common Retirement Fund | 0.01% | Add +3.8% | 1,208,867 | $9.7M |
| Bank of New York Mellon Corp | 0.00% | Add +24.0% | 1,034,760 | $8.3M |
| Jane Street Group, LLC | 0.01% | Add +0.9% | 1,030,312 | $8.3M |
| Artal Group S.A. | 0.21% | New | 1,011,500 | $8.1M |
| Susquehanna International Group, LLP | 0.01% | Reduce -45.4% | 991,649 | $8.0M |
| Norges Bank | 0.00% | Reduce -13.7% | 942,983 | $7.6M |
| Pictet Asset Management Holding SA | 0.01% | Reduce -71.7% | 920,077 | $7.4M |
| Rhenman & Partners Asset Management AB | 0.71% | Reduce -3.7% | 920,000 | $7.4M |
| Opaleye Management Inc. | 1.67% | No change | 897,000 | $7.2M |
| UBS Group AG | 0.00% | Add +15.1% | 795,204 | $6.4M |
| Orion Investment Co | 2.54% | — | 794,700 | $6.4M |
| Two Sigma Investments, LP | 0.02% | New | 774,783 | $6.2M |
| Schroder Investment Management Group | 0.01% | Add +132.5% | 769,160 | $6.2M |
| Boxer Capital, LLC | 0.32% | No change | 750,000 | $6.0M |
| Group One Trading LLC | 0.18% | Add +49.9% | 731,607 | $5.9M |
| Rafferty Asset Management, LLC | 0.02% | Add +24.0% | 724,179 | $5.8M |
| Deutsche Bank AG | 0.00% | Reduce -1.3% | 714,367 | $5.7M |
| QVT Financial LP | 0.53% | No change | 678,564 | $5.4M |
| Banque Pictet & Cie SA | 0.05% | Reduce -3.0% | 668,650 | $5.4M |
| D. E. Shaw & Co. | 0.01% | Reduce -72.1% | 655,830 | $5.3M |
| Candriam S.C.A. | 0.02% | Reduce -52.8% | 500,033 | $4.0M |
| Tang Capital Management LLC | 0.41% | No change | 500,000 | $4.0M |
| SG Americas Securities, LLC | 0.03% | Add +836.5% | 498,390 | $4.0M |
| Wells Fargo & Company | 0.00% | Add +35.0% | 496,396 | $4.0M |
| Zimmer Partners, LP | 0.07% | Add +992.0% | 475,000 | $3.8M |
| BNP Paribas Financial Markets | 0.00% | Add +218.0% | 464,052 | $3.7M |
| Swiss National Bank | 0.00% | Add +1.4% | 384,456 | $3.1M |
| Capital Fund Management S.A. | 0.03% | New | 383,260 | $3.1M |
| Rhumbline Advisers | 0.00% | Reduce -5.8% | 368,800 | $3.0M |
| Hennion & Walsh Asset Management, Inc. | 0.15% | Reduce -9.6% | 368,152 | $3.0M |
| Panagora Asset Management Inc. | 0.01% | Add +11.6% | 361,187 | $2.9M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -6.5% | 335,513 | $2.7M |
| Alliancebernstein L.P. | 0.00% | Add +4.6% | 330,032 | $2.6M |
| Vestal Point Capital, LP | 0.18% | New | 300,000 | $2.4M |
| Tudor Investment Corporation | 0.03% | Add +22.6% | 299,885 | $2.4M |
| TD Asset Management Inc | 0.00% | Reduce -43.6% | 284,878 | $2.3M |
| Sei Investments Co. | 0.00% | Reduce -14.5% | 284,761 | $2.3M |
| Barclays PLC | 0.00% | Add +8.2% | 276,300 | $2.2M |
| Parametrica Management Ltd | 2.77% | Add +98.4% | 261,090 | $2.1M |
| Squarepoint Ops LLC | 0.01% | New | 257,543 | $2.1M |
| CM Management, LLC | 1.84% | No change | 250,000 | $2.0M |
| Hudson Bay Capital Management LP | 0.02% | Add +400.0% | 250,000 | $2.0M |
| LPL Financial LLC | 0.00% | Add +1.3% | 243,839 | $2.0M |
| Citadel Advisors | 0.00% | Reduce -78.1% | 243,258 | $2.0M |
| State of Wisconsin Investment Board | 0.01% | Add +48.4% | 236,369 | $1.9M |
| Legal & General Group Plc | 0.00% | Add +7.2% | 218,504 | $1.8M |
| Invesco Ltd. | 0.00% | Reduce -1.3% | 214,069 | $1.7M |
| Neo Ivy Capital Management | 0.33% | — | 212,648 | $1.7M |
| American Century Companies Inc. | 0.00% | Reduce -40.0% | 203,038 | $1.6M |
| Qube Research & Technologies Ltd | 0.00% | Add +264.3% | 200,401 | $1.6M |
| NFJ Investment Group, LLC | 0.05% | Reduce -6.5% | 198,430 | $1.6M |
| California State Teachers Retirement System | 0.00% | Reduce -0.7% | 195,180 | $1.6M |
| Quantitative Investment Management, LLC | 0.16% | New | 187,508 | $1.5M |
| Voya Investment Management LLC | 0.00% | Reduce -13.5% | 172,885 | $1.4M |
| Millennium Management | 0.00% | Reduce -89.7% | 166,149 | $1.3M |
| Stifel Financial Corp. | 0.00% | Reduce -36.4% | 164,320 | $1.3M |
| Raymond James Financial Services Advisors, Inc. | 0.00% | Add +16.3% | 159,100 | $1.3M |
| PFM Health Sciences, LP | 0.07% | Reduce -50.8% | 152,795 | $1.2M |
| MetLife Investment Management, LLC | 0.01% | Add +20.9% | 146,416 | $1.2M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 145,760 | $1.2M |
| Citigroup Inc. | 0.00% | Reduce -74.4% | 138,182 | $1.1M |
| Baird Financial Group, Inc. | 0.00% | Add +1164.8% | 136,600 | $1.1M |
| Royal Bank of Canada | 0.00% | Add +37.5% | 136,334 | $1.1M |
| Corebridge Financial, Inc. | 0.01% | — | 136,213 | $1.1M |
| Aberdeen Group plc | 0.00% | New | 131,800 | $1.1M |
| Great Lakes Advisors, LLC | 0.01% | Reduce -2.7% | 125,503 | $1.0M |
"% of holder's portfolio" is IOVA's weight in each manager's 13F, not the share of Iovance Biotherapeutics Inc. the manager owns.